A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B
Clinical trial NCT01662531 · COMPLETED
Trial details
- NCT number
- NCT01662531
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-10-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.